Figure legends
Figure 1. PRISMA flow diagram of study selection process
Figure 2. Forest plot for comorbidities associated with diabetes vs. non-diabetic exposed with COVID-19
Blue squares and horizontal lines represent study-specific estimates and 95% CI. The size of the square is proportional to the weights of the individual studies. Black diamond represents pooled estimates (center) and 95% CI (width).
Figure 2.1: Chronic kidney disease (CKD);2.2: Chronic liver disease (CLD); 2.3: Acute respiratory distress syndrome (ARDS); 2.4: Cardiovascular disease (CVD) 2.5: Chronic obstructive pulmonary disease (COPD); 2.6: Thyroid disease; 2.7: Acute kidney injury (AKI); 2.8: Hypertension; 2.9: Cerebrovascular Diseases; 2.10: Acute Cardiac Injury; 2.11: Digestive disease; 2.12: Cancer; 2.13: Septic Shock
Figure 3. Forest plot for diabetes associated outcomes vs. non-diabetic exposed with COVID-19
Blue squares and horizontal lines represent study-specific estimates and 95% CI. The size of the square is proportional to the weights of the individual studies. Black diamond represents pooled estimates (center) and 95% CI (width).
Outcomes comprised of; Mortality, Recovered, Hospitalization, Mechanical ventilation, ICU (Intensive care unit) admission, length of stay (LOS), Discharge from hospital
Figure 3.1: Mortality; 3.2: Recovered;3.3: Length of stay (LOS); 3.4: Mechanical ventilation; 3.5: ICU (Intensive care unit) admission;3.6: Discharge from hospital; 3.7: Hospitalization
Table 1. Characteristics of included studies